Solas Capital Loads Kyndryl: What Investors Should Know
A notable new stake in Kyndryl signals growing confidence from a private equity–style shop. This deep dive explains w...
Hedge Funds
Explore a curated set of 5 Hedge Funds articles, from Tepper's AI bets to Ackman's AI moves, showing how big bets can influence risk, diversification, and portfolio growth.
77 articles
Apis Capital Triples Down on Turning Point Brands—New $10M Stake
A patient fund manager shows strong conviction, piling another $10 million into Turning Point Brands. The move highli...
Starboard Value Takes Stake in Fluor as Cycles Turn
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
Billionaire David Tepper Sold: What It Signals for Investors
When a billionaire like David Tepper reportedly sold stakes in Nvidia and Amazon, it raises questions for regular inv...
Black Cypress Doubles Down on Floor & Decor Investment
When insider-like conviction meets market risk, funds can double down on a stock. This analysis explains why Black Cy...
Crocs Stock Draws Million Bet Despite 12% Drop Year
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
What Know About Million: Decoding a $34M TDS Exit
A single hedge fund exit can move a stock as much as a major earnings beat. This guide breaks down a $34 million TDS ...
Billionaire Bill Ackman Just Bets on Cheap Magnificent Seven
When high-profile investors tilt toward value, curious readers take note. This piece breaks down why billionaire Bill...
Apis Capital Expands Garrett Stake as Hybrid Demand Rises
A major hedge fund recently boosted its Garrett Motion position, highlighting how hybrid powertrain trends are reshap...
Billionaire Stephen Mandel Dumped Meta; Lone Pine's AI Pivot
A major portfolio pivot is unfolding as 13F data reveals a famous hedge fund manager changing course. Learn why billi...
Disc Medicine Stock Swinging, Yet a Fund Bet Shines
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...